Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By stimulating these https://kianaqrio843702.blogdun.com/36954706/retatrutide-a-promising-new-treatment-for-obesity